Wellbutrin Hair Loss: Risk, Timeline & Fixes

Wellbutrin hair loss (bupropion) is best handled with timeline logic, because most medication-linked shedding behaves like telogen effluvium (TE): the trigger happens first, and shedding becomes noticeable later. Importantly, FDA labeling documents an alopecia signal for bupropion products (for example, Wellbutrin XL labeling lists alopecia among skin adverse reactions; another bupropion label lists “Dermatologic: Infrequent was alopecia”). This does not prove causation in an individual case—but it establishes a real adverse-event signal that belongs on the differential when timing and pattern fit.

Medical note: This article is for general education and does not provide personal medical advice. Do not stop or change Wellbutrin/bupropion without clinician guidance. If you’re not sure whether you’re seeing shedding or breakage, start here: Shedding vs Breakage. If the diagnosis is unclear, start here: How Hair Loss Is Diagnosed. If you have scalp pain/burning, pustules/crusting, heavy scale, open sores, or rapid worsening, start here: When to See a Doctor.

Wellbutrin hair loss: FDA label alopecia listing, cohort HR 1.46 vs fluoxetine, TE timing (2–4 months), pattern clues, labs to consider, and practical next steps. — Most medication-linked hair loss fits delayed TE logic. The fastest way to avoid misdiagnosis is matching onset to the timeline and the pattern.

Quick navigation

Key takeaways (fast)
Evidence: what’s actually measurable
What FDA labels say about alopecia
Timeline: onset, peak, recovery (TE logic)
Pattern clues: TE vs AGA vs AA vs breakage
When labs matter (targeted workup)
What to do (practical plan)
When to see a doctor
Related on this site
References

Key takeaways (fast)

FDA label signal: bupropion product labeling includes alopecia among reported adverse reactions (label phrasing varies by product/formulation).
Comparative risk signal: a large population-based cohort study found bupropion had the highest risk of hair loss compared with several antidepressants; vs fluoxetine, HR was 1.46 (NNH ≈ 242 over 2 years).
TE timing is delayed: DermNet notes increased hair fall is often noticed 2 to 4 months after the trigger; BAD notes it can occur around 3 months after a trigger.
Do not self-stop: if timing fits, the right move is clinician-guided risk/benefit + timeline review + alternatives if needed.
Related on this site: Medication-Related Shedding • Telogen Effluvium • Blood Tests & Workup.

Evidence: what’s actually measurable

Two evidence types are “high-yield” here: (1) label signal (alopecia appears in bupropion labeling), and (2) comparative real-world risk from a large health-claims cohort. In the cohort study, bupropion had the highest relative risk for a hair-loss diagnosis among the antidepressants compared, with HR 1.46 vs fluoxetine (and NNH ≈ 242 over 2 years). This is observational data (not proof of causality for one person), but it’s a concrete signal you can combine with timeline + pattern.

What FDA labels say about alopecia

FDA labeling documents an alopecia signal for bupropion products. For example, Wellbutrin XL labeling lists alopecia among skin adverse reactions, and another bupropion label lists “Dermatologic: Infrequent was alopecia.” What labels generally do not provide is a clean, universally applicable incidence rate—so you still need timeline + pattern to interpret a suspected case.

Timeline: onset, peak, recovery (TE logic)

Onset (typical TE window): DermNet notes increased hair fall is often noticed 2 to 4 months after the triggering event; BAD notes it can occur around 3 months after a trigger.
Peak: TE often feels worst for several weeks once it starts.
Recovery: once triggers stabilize (often via clinician-guided medication strategy + correcting overlaps), shedding usually slows first; density recovery takes longer.

Pattern clues: TE vs AGA vs AA vs breakage

Most consistent with TE: diffuse shedding, normal-looking scalp, delayed timing after starting Wellbutrin or changing dose.
TE + AGA overlap: if shedding slows but the part/crown keeps widening, consider TE unmasking pattern hair loss: TE vs Androgenetic Alopecia.
Patchy smooth bald spots: consider alopecia areata: Alopecia Areata Hub.
Lots of short snapped hairs: consider breakage: Hair Breakage (Hair-Shaft).

When labs matter (targeted workup)

If shedding is heavy, persistent, or recurrent, clinicians often screen for overlap triggers (iron status, thyroid issues, etc.). Use your structured page:

Blood Tests & Workup

What to do (practical plan)

Build a timeline: start date, dose changes, and the exact month shedding became noticeable.
Confirm the pattern: TE vs breakage vs overlap AGA vs AA (links above).
Talk to the prescriber: if timing fits, discuss options (watchful waiting vs dose adjustment vs switch) based on mental-health and smoking-cessation risk/benefit. Do not self-stop.
Unstack triggers: stabilize nutrition, avoid crash dieting, correct deficiencies if proven.
Track monthly: photos every 4 weeks (same angle/light).

When to see a doctor

Scalp pain/burning, pustules, open sores, heavy scale/crusting
Patchy smooth bald spots
Shedding persisting beyond ~6 months or recurrent waves

Start here: When to See a Doctor.

References (trusted sources)

Last updated: March 07, 2026.